Aliskiren/amlodipine/hydrochlorothiazide

Aliskiren/amlodipine/hydrochlorothiazide
Combination of
Aliskiren Renin inhibitor
Amlodipine Calcium channel blocker
Hydrochlorothiazide Diuretic
Clinical data
AHFS/Drugs.com Consumer Drug Information
Licence data US FDA:link
  • US: D (Evidence of risk)
Oral
Identifiers
C09XA54
 Yes (what is this?)  (verify)

The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1]

References

  1. Amturnide approval letter. U.S. Food and Drug Administration (FDA).

External links